Lv5
1060 积分 2024-01-29 加入
Resistance mechanisms of SARS-CoV-2 3CLpro to the non-covalent inhibitor WU-04
2天前
已完结
Analysis of Structure–Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei
2天前
已关闭
Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro
2天前
待确认
Structure‐Based Development of Ultra‐Broad‐Spectrum 3C‐Like Protease Inhibitors
2天前
已完结
Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening
2天前
已完结
Discovery of Novel Nonpeptidic and Noncovalent Small Molecule 3CLpro Inhibitors as anti-SARS-CoV-2 Drug Candidate
2天前
已完结
Rational design and optimization of acylthioureas as novel potent influenza virus non-nucleoside polymerase inhibitors
7天前
已完结
Modulating active targeting nanoparticle design according to tumor progressions
7天前
已完结
Modulating active targeting nanoparticle design according to tumor progressions
7天前
已完结
Structural Optimization of Next-Generation TRK Inhibitors against Acquired Drug Resistance Mutations for the Treatment of Solid Tumors
7天前
已完结
皖公网安备34019202002308
